NEW YORK (GenomeWeb News) – Investment bank Piper Jaffray has upgraded its rating on Becton Dickinson's stock to Overweight and increased its price target.

Analyst William Quirk cited increased interest in microbiology diagnostic systems and BD's position in the market in a research note explaining the upgrade. In addition, he said BD could be poised to gain market share following a recent recall by Siemens of its MicroScan microbiology testing panels in the US.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.